LANCL1 as the Key Immune Marker in Neuropathic Pain

Neural Plast. 2022 Apr 25:2022:9762244. doi: 10.1155/2022/9762244. eCollection 2022.

Abstract

Objective: This study is to explore key immune markers and changes of immune microenvironment in neuropathic pain (NeuP).

Method: The data sets of GSE145199 and GSE145226 in Gene Expression Omnibus (GEO) database was used to analyze, and the key immune markers were verified by GSE70006 and GSE91396, and the infiltration degree of immune cells in different samples were analyzed by CIBERSORT analysis package.

Results: In this study, we found a key immune marker, namely, LANCL1. Regulatory axis closely related to LANCL1 has also been found, namely, miR-6325/LANCL1 axis. In the immune infiltration analysis, we also found that the LANCL1 is positively correlated with T cells CD4 naïve (r = 0.880, p < 0.05).

Conclusion: In this study, we found that LANCL1 may be a protective factor for NeuP, and the miR-6325/LANCL1 axis may be involved in the occurrence and development of NeuP. Cascade reactions including mast cells, macrophages, and T cells may be an important reason for the aggravation of nerve damage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Databases, Factual
  • Humans
  • Macrophages
  • MicroRNAs* / genetics
  • Neuralgia*
  • Receptors, G-Protein-Coupled

Substances

  • Biomarkers
  • LANCL1 protein, human
  • MicroRNAs
  • Receptors, G-Protein-Coupled